1. Brass EP, Anthony R, Dormandy J, Hiatt WR, Jiao J, Nakanishi A,
et al. Parenteral therapy with lipo-ecraprost, a lipid-based formulation
of a PGE1 analog, does not alter six-month outcomes in patients with
critical leg ischemia. J Vasc Surg 2006;43:752-9.
12. Marston WA, Davies SW, Armstrong B, Farber